Fig. 1.
Fig. 2.
Baseline patient characteristics_
| Characteristics | Biologic therapy – IFX (n = 13) | EEN (n = 48) | Control group (n = 17) |
|---|---|---|---|
| Male:Female, n (%) | 7 (54%):6 (46%) | 29 (60%):19 (40%) | 9 (53%):8 (47%) |
| Age at diagnosis, months; mean (± SD) | 137 (± 48.15) | 160.27 (± 37.11) | N/A |
| Age at initial treatment, months; mean (± SD) | 157.15 (± 45.16) | 160.27 (± 37.11) | N/A |
| Weight, kg; mean (± SD) | 41.97 (± 16.3) | 40.93 (± 14.05) | 42.8 (± 17.2) |
| Height, cm; mean (± SD) | 149.95 (± 20.31) | 155.3 (± 19.1) | 148.7 (± 18.8) |
| BMI, kg/m2; mean (± SD) | 17.89 (± 3.62) | 16.4 (± 2.92) | 18.3 (± 3.8) |
| PCDAI-1; mean (± SD) | 47.5 (± 16.43) | 32.03 (± 15.01) | N/A |
| PCDAI-2; mean (± SD) | 9.04 (± 6.5) | 5.93 (± 11.36) | N/A |